The three A-share indexes opened low in the morning, and the gem index once fell by more than 1.5%. Then the index rebounded, the Shanghai index turned red, and the decline of Shenzhen Component Index and gem index narrowed significantly. Baijiu plate early opened low after the shock rebound. Insurance, cro and coal sectors were active, real estate stocks rebounded across the board, national defense and military industry led the rise strongly, high-level lithium battery stocks were sharply divided, and some leading stocks remained strong, but the overall plate effect was poor. The semiconductor sector rebounded near midday. In the afternoon, the index weakened again, with the gem index down 1.31%, the Shenzhen composite index down 1.06% and the Shanghai index down 0.57%. The military industry sector continued to strengthen in the afternoon, with Xinyan shares, aerospace rainbow, China coastal defense, Chinese ships and other trading limits. The seed industry stocks moved up, and Longping high tech pulled up the touchpad in a straight line. Baijiu, semiconductor, household appliances and other sectors weakened, the securities sector continued to weaken, and Oriental Securities fell nearly 5%. Overall, market sentiment continued to fall, more than 3200 shares in the two markets fell, and the transaction volume in Shanghai and Shenzhen exceeded 1 trillion yuan for the 12th consecutive trading day. On the disk, most of the sectors fell, led by the sectors of national defense and military industry, seed industry, tourism, catering and real estate, and led by the sectors of computer application, new chemical materials and nonferrous metals.
1. Xinhua News Agency: beware of the flow of e-cigarettes to minors
Xinhua News Agency reporter’s recent investigation found that although the state has expressly stipulated that all kinds of market subjects are not allowed to sell e-cigarettes to minors, some e-cigarettes wrapped in “gorgeous coats” are still penetrating into minors, and some potential risks are also worthy of vigilance.
2. Xinhua viewpoint: if you are anxious about your height, you should play “heightening needle”? DANGER
Xinhua viewpoint pointed out that in recent years, the “heightening needle” treatment mainly used for dwarfism in medicine has quietly sprung up. The survey found that the so-called “heightening needle” is actually an injection of growth hormone. Experts believe that growth hormone has been abused, which may bring users health risks such as endocrine disorder, femoral head slippage, scoliosis and so on.
3. Research shows that some cancers are related to drinking
The website of the Ministry of science and technology disclosed that a Canadian study showed that some cancers were related to drinking. The article said that alcohol is a class 1 carcinogen defined by the international agency for research on cancer (IARC) of the World Health Organization. It is the main cause of cancer in the world, and the number of cancers will further rise with the increase of alcohol consumption.
4. The 5g message working group established a 5g message joint laboratory with 7 units such as Huawei
According to the official wechat of Taiyue in Shenzhou, the 5g message working group has established a 5g message joint laboratory jointly with 7 units, including China Communication Enterprise Association, China information and Communication Research Institute, China Telecom Group, China mobile communication group, China United Network Communication Group, ZTE and Huawei, to carry out technical verification related to 5g messages. It is planned to hold the unveiling ceremony of the joint laboratory at the 2021 China value-added telecom and virtual operation Summit Forum, and launch the first 5g message terminal certification in the same period.
5. Changchun hi tech responded to growth hormone abuse: relevant products are sold to legal medical institutions
Changchun hi tech responded on the interactive platform that the company produces and operates in strict accordance with the requirements of laws and regulations. Growth hormone is a prescription drug. The state has strict laws and regulations on the sales of growth hormone, such as the drug administration law and the Anti Doping regulations. Relevant products are sold to medical institutions that meet the requirements of laws and regulations.